These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 25897788)
1. Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012. Bretaña NA; Boelen L; Bull R; Teutsch S; White PA; Lloyd AR; Luciani F; Emerg Infect Dis; 2015 May; 21(5):765-74. PubMed ID: 25897788 [TBL] [Abstract][Full Text] [Related]
2. Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs. Snow KJ; Young JT; Preen DB; Lennox NG; Kinner SA BMC Public Health; 2014 Aug; 14():830. PubMed ID: 25113132 [TBL] [Abstract][Full Text] [Related]
3. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017. Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825 [TBL] [Abstract][Full Text] [Related]
4. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study. Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J; J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances. Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650 [TBL] [Abstract][Full Text] [Related]
7. Violence and hepatitis C transmission in prison-A modified social ecological model. Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L PLoS One; 2020; 15(12):e0243106. PubMed ID: 33259565 [TBL] [Abstract][Full Text] [Related]
8. Tattooing in prisons--not such a pretty picture. Hellard ME; Aitken CK; Hocking JS Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561 [TBL] [Abstract][Full Text] [Related]
9. HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection. Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FM; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL Infect Genet Evol; 2016 Jan; 37():252-8. PubMed ID: 26631810 [TBL] [Abstract][Full Text] [Related]
10. Presence of hepatitis C virus in syringes confiscated in prisons in Australia. Dolan K; Larney S; Jacka B; Rawlinson W J Gastroenterol Hepatol; 2009 Oct; 24(10):1655-7. PubMed ID: 19788605 [TBL] [Abstract][Full Text] [Related]
11. Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa. Forbi JC; Purdy MA; Campo DS; Vaughan G; Dimitrova ZE; Ganova-Raeva LM; Xia GL; Khudyakov YE J Gen Virol; 2012 Jul; 93(Pt 7):1410-1421. PubMed ID: 22456613 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in Prisons. Lim AG; Stone J; Hajarizadeh B; Byrne M; Chambers GM; Martin NK; Grebely J; Dore GJ; Lloyd AR; Vickerman P Hepatology; 2021 Nov; 74(5):2366-2379. PubMed ID: 34105797 [TBL] [Abstract][Full Text] [Related]
13. A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events. Olmstead AD; Joy JB; Montoya V; Luo I; Poon AF; Jacka B; Lamoury F; Applegate T; Montaner J; Khudyakov Y; Grebely J; Cook D; Harrigan PR; Krajden M Infect Genet Evol; 2015 Jul; 33():101-9. PubMed ID: 25917496 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia. Gates JA; Post JJ; Kaldor JM; Pan Y; Haber PS; Lloyd AR; Dolan KA; J Urban Health; 2004 Sep; 81(3):448-52. PubMed ID: 15273267 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors. Miller ER; Bi P; Ryan P Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study. Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):533-546. PubMed ID: 33965006 [TBL] [Abstract][Full Text] [Related]
18. Understanding hepatitis C virus (HCV) health literacy and educational needs among people in prison to enhance HCV care in prisons. Sheehan Y; Cochrane A; Treloar C; Grebely J; Tedla N; Lloyd AR; Lafferty L Int J Drug Policy; 2024 Aug; 130():104516. PubMed ID: 38996643 [TBL] [Abstract][Full Text] [Related]
19. A prospective study of hepatitis C incidence in Australian prisoners. Luciani F; Bretaña NA; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR; Addiction; 2014 Oct; 109(10):1695-706. PubMed ID: 24916002 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison. Okafor IM; Ugwu SO; Okoroiwu HU BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]